Financials in USD. Standardized financial statements.
A compact view of how Therapeutic Solutions International, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $98,994 | $206,767 | $145,956 | $62,681 | $27,495 | $3,484 | $2,851 | $5,009 | $1,911 | $268,892 |
| Revenue Growth? | -52.1% | +41.7% | +132.9% | +128.0% | +689.2% | +22.2% | -43.1% | +162.1% | -99.3% | 0.0% |
| Cost of Revenue? | $36,768 | $79,440 | $42,544 | $12,792 | $3,015 | $2,157 | $823 | $1,606 | $3,193 | $26,798 |
| Gross Profit? | $62,226 | $127,327 | $103,412 | $49,889 | $24,480 | $1,327 | $2,028 | $3,403 | -$1,282 | $242,094 |
| Gross Margin? | +62.9% | +61.6% | +70.9% | +79.6% | +89.0% | +38.1% | +71.1% | +67.9% | -67.1% | +90.0% |
| Operating Expenses? | $2.05M | $3.21M | $2.41M | $1.90M | $1.07M | $1.20M | $886,295 | $1.05M | $569,653 | $327,105 |
| Operating Income? | -$1.99M | -$3.28M | -$2.30M | -$1.85M | -$1.04M | -$1.20M | -$884,267 | -$1.04M | -$570,935 | -$327,105 |
| EBITDA? | -$1.49M | -$2.99M | -$2.33M | -$1.89M | -$1.34M | -$1.20M | -$884,267 | -$1.04M | -$545,937 | -$305,973 |
| Income Before Tax | -$2.22M | -$3.88M | -$2.96M | -$2.20M | -$1.70M | -$1.87M | -$995,472 | -$1.06M | -$572,619 | -$537,752 |
| Income Tax Expense | $2,250 | $1,600 | $800 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$2.17M | -$3.81M | -$2.96M | -$2.20M | -$1.70M | -$1.87M | -$995,472 | -$1.06M | -$586,441 | -$288,750 |
| EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality